CHEMOTHERAPY. Volume 4 Pharmacology of Antibiotics

Similar documents
Pharmacology Week 6 ANTIMICROBIAL AGENTS

Treatment of Respiratory Tract Infections Prof. Mohammad Alhumayyd Dr. Aliah Alshanwani

مادة االدوية المرحلة الثالثة م. غدير حاتم محمد

Cell Wall Inhibitors. Assistant Professor Naza M. Ali. Lec 3 7 Nov 2017

Introduction to Chemotherapeutic Agents. Munir Gharaibeh MD, PhD, MHPE School of Medicine, The university of Jordan November 2018

Considerations in antimicrobial prescribing Perspective: drug resistance

Antimicrobial Update. Alison MacDonald Area Antimicrobial Pharmacist NHS Highland April 2018

Pharmacokinetics. Antibiotics and Chemotherapy. Vol. 25

Microbiology ( Bacteriology) sheet # 7

Suggestions for appropriate agents to include in routine antimicrobial susceptibility testing

مادة االدوية المرحلة الثالثة م. غدير حاتم محمد

SUMMARY OF PRODUCT CHARACTERISTICS

USA Product Label CLINTABS TABLETS. Virbac. brand of clindamycin hydrochloride tablets. ANADA # , Approved by FDA DESCRIPTION

1. The preferred treatment option for an initial UTI episode in a 22-year-old female patient

Proceedings of the 13th International Congress of the World Equine Veterinary Association WEVA

CHEMOTHERAPY. Volume 6 Parasites, Fungi, and Viruses

Comparison of antibiotic susceptibility results obtained with Adatab* and disc methods

Principles of Antimicrobial therapy

Cell Wall Weakeners. Antimicrobials: Drugs that Weaken the Cell Wall. Bacterial Cell Wall. Bacterial Resistance to PCNs. PCN Classification

GENERAL NOTES: 2016 site of infection type of organism location of the patient

Medicinal Chemistry 561P. 2 st hour Examination. May 6, 2013 NAME: KEY. Good Luck!

RELIABLE AND REALISTIC APPROACH TO SENSITIVITY TESTING

Anaerobic and microaerophilic gram-positive cocci Peptococcus species, Peptostreptococcus species, Microaerophilic streptococci

Protein Synthesis Inhibitors

Antibiotic Prophylaxis in Spinal Surgery Antibiotic Guidelines. Contents

Other Beta - lactam Antibiotics

Principles of Anti-Microbial Therapy Assistant Professor Naza M. Ali. Lec 1

Burton's Microbiology for the Health Sciences. Chapter 9. Controlling Microbial Growth in Vivo Using Antimicrobial Agents

** the doctor start the lecture with revising some information from the last one:

SUMMARY OF PRODUCT CHARACTERISTICS

Antibacterial therapy 1. د. حامد الزعبي Dr Hamed Al-Zoubi

Chapter 51. Clinical Use of Antimicrobial Agents

Approach to pediatric Antibiotics

SUMMARY OF PRODUCT CHARACTERISTICS. Cephacare flavour 50 mg tablets for cats and dogs. Excipients: For a full list of excipients, see section 6.1.

Part II SUMMARY OF PRODUCT CHARACTERISTICS. Each tablet contains 25 mg Clindamycin (as Clindamycin Hydrochloride)

UTI Dr S Mathijs Department of Pharmacology

number Done by Corrected by Doctor Dr Hamed Al-Zoubi

Antibiotics A Multidisciplinary Approach

Microbiology : antimicrobial drugs. Sheet 11. Ali abualhija

B. PACKAGE LEAFLET 1

Amoxicillin Introduction: Mechanism of action: Pharmacology: Indications: Dosage: 12 Weeks ( 3 Months):

Selective toxicity. Antimicrobial Drugs. Alexander Fleming 10/17/2016

Childrens Hospital Antibiogram for 2012 (Based on data from 2011)

Antimicrobial Therapy

Unasyn alternative if penicillin allergic

21 st Expert Committee on Selection and Use of Essential Medicines Peer Review Report Antibiotics Review

ESSENTIALS OF ANTIMICROBIAL PHARMACOLOGY

VCH PHC SURGICAL PROPHYLAXIS RECOMMENDATIONS

APPROVED PACKAGE INSERT. Each capsule contains clindamycin hydrochloride equivalent to 150 mg clindamycin base.

Author - Dr. Josie Traub-Dargatz

Antibiotics. Antimicrobial Drugs. Alexander Fleming 10/18/2017

Antibiotics 1. Lecture 8

Help with moving disc diffusion methods from BSAC to EUCAST. Media BSAC EUCAST

Health Products Regulatory Authority

Foundation in Pharmacology - 2 (Year 3 Semester 1)

General Approach to Infectious Diseases

Introduction to Antimicrobial Therapy

Is erythromycin bactericidal

SUMMARY OF PRODUCT CHARACTERISTICS

by adding different antibiotics to sera containing

Inhibiting Microbial Growth in vivo. CLS 212: Medical Microbiology Zeina Alkudmani

Prophylactic antibiotic timing and dosage. Dr. Sanjeev Singh AIMS, Kochi

10/15/08. Activity of an Antibiotic. Affinity for target. Permeability properties (ability to get to the target)

Similar to Penicillins: -Chemically. -Mechanism of action. -Toxicity.

2018 OPTIONS FOR INDIVIDUAL MEASURES: REGISTRY ONLY. MEASURE TYPE: Process

بسم هللا الرحمن الرحيم

Mercy Medical Center Des Moines, Iowa Department of Pathology. Microbiology Department Antibiotic Susceptibility January December 2016

SUMMARY OF PRODUCT CHARACTERISTICS

Antibiotic Resistance in Bacteria

Women s Antimicrobial Guidelines Summary

Antimicrobial Update Stewardship in Primary Care. Clare Colligan Antimicrobial Pharmacist NHS Forth Valley

Intro Who should read this document 2 Key practice points 2 Background 2

Can levaquin treat group b strep

Beta-lactams 1 รศ. พญ. มาล ยา มโนรถ ภาคว ชาเภส ชว ทยา. Beta-Lactam Antibiotics. 1. Penicillins 2. Cephalosporins 3. Monobactams 4.

SUMMARY OF PRODUCT CHARACTERISTICS

Antimicrobials. Antimicrobials

Chapter 12. Antimicrobial Therapy. Antibiotics 3/31/2010. Spectrum of antibiotics and targets

EAGAR Importance Rating and Summary of Antibiotic Uses in Humans in Australia

جداول میکروارگانیسم های بیماریزای اولویت دار و آنتی بیوتیک های تعیین شده برای آزمایش تعیین حساسیت ضد میکروبی در برنامه مهار مقاومت میکروبی

SUMMARY OF PRODUCT CHARACTERISTICS. Active substance: cefalexin (as cefalexin monohydrate) mg

The β- Lactam Antibiotics. Munir Gharaibeh MD, PhD, MHPE School of Medicine, The University of Jordan November 2018

Intrinsic, implied and default resistance

ANTIMICROBIAL DOSING GUIDE 2013

1. A patient with an allergy to sulfa (sulfonamides) should not take A) Augmentin. B) tetracycline. C) minocycline D) Bactrim DS.

Clinical Practice Standard

Veterinary Medicinal Product

Routine internal quality control as recommended by EUCAST Version 3.1, valid from

2019 COLLECTION TYPE: MIPS CLINICAL QUALITY MEASURES (CQMS) MEASURE TYPE: Process High Priority

Introduction to Pharmacokinetics and Pharmacodynamics

UPDATES ON ANTIBIOTIC THERAPY. Jennifer L. Davis, DVM, PhD, DACVIM (LA), DACVCP VA-MD College of Veterinary Medicine VA Tech, Blacksburg, VA

Antibiotics have no (or only minimal) effect on human cells and tissues - their action is directed specifically against micro-organisms.

January 2014 Vol. 34 No. 1

Bacterial skin and soft tissues infections (SSTI) are one of the most common 1. infections among different age groups

Cork and Kerry SARI Newsletter; Vol. 2 (2), December 2006

BUGS and DRUGS Part 1 March 6, 2013 Marieke Kruidering- Hall

January 2014 Vol. 34 No. 1

Pinni Meedha Mojutho Ammanu Dengina Koduku Part 1 Kama Kathalu

choice The Rilexine Palatable Tablets First generation cephalosporin for skin infections Now registered for ONCE daily administration*

Pharm 262: Antibiotics. 1 Pharmaceutical Microbiology II DR. C. AGYARE

Metacam 1.5 mg/ml oral suspension for dogs

Transcription:

CHEMOTHERAPY Volume 4 Pharmacology of Antibiotics

CHEMOTHERAPY Volume 1 Clinical Aspects of Infections Prophylaxis; life-threatening infections; infection in leukaemia; surgical infection; anaerobic infection; respiratory and urinary tract infections; amikacin. Volume 2 Volume 3 Volume 4 Volume 5 Volume 6 Volume 7 Volume 8 Laboratory Aspects of Infections Sensitivity testing; assay methods; animal models of infection; sisomycin; tobramycin_ Special Problems in Chemotherapy Tuberculosis; genital tract infections; antibiotic resistance and mode of action; topical chemotherapy and antisepsis_ Pharmacology of Antibiotics Tissue concentrations; pharmacokinetics; untoward effects of antibiotics. Penicillins and Cephalosporins Penicillins and cephalosporins; betalactamases; new agents. Parasites, Fungi, and Viruses Parasitic infections; fungal infections; chemotherapy of viruses; co-trimoxazole. Cancer Chemotherapy I Symposia - new drugs and approaches; cell and pharmacokinetics; potentiators of radiotherapy; in vitro screening systems; immunological aspects. Cancer Chemotherapy II Free papers - new drugs and approaches; cell and pharmacokinetics; mechanisms of action; new analogues; cancer chemotherapy of specific organs.

CHEMOTHERAPY VoluIlle 4 Pharmacology of Antibiotics Edited by 1. D Williams The London Hospital Medical CoUege London, U. K. and A.M. Geddes East Birmingham Hospital Birmingham, u.k. Plenum Press New York and London

Library of Congress Cataloging in Publication Data International Congress of Chemotherapy, 9th, London, 1975. Pharmacology of antibiotics. (Chemotherapy;v.4) 1. Antibiotics - Congresses. 2. Antibiotics - Side effects - Congresses. I. Williams, John David, M.D. II. Geddes, Alexander McIntosh. III. Title. IV. Series. RM260.2.C45 vol. 4 [RM265.2] 615'.585 [615'.329] 76-1946 Proceedings of the Ninth International Congress of Chemotherapy held in London, July, 1975 will be published in eight volumes, of which this is volume four. ISBN 978-1-4684-3125-4 ISBN 978-1-4684-3123-0 (ebook) DOl 10.1007/978-1-4684-3123-0 1976 Plenum Press, New York Softcover reprint of the hardcover I st edition 1976 A Division of Plenum Publishing Corporation 227 West 17th Street, New York, N.Y. 10011 United Kingdom edition published by Plenum Press, London A Division of Plenum Publishing Company, Ltd. Davis House (4th Floor), 8 Scrubs Lane, Harlesden, London, MWI0 6SE, England All rights reserved No part of this book may be reproduced, stored in a retrieval system, or transmitted, in any form or by any means, electronic, mechanical, photocopying, microfilming, recording, or otherwise, without written permission from the Publisher

CHEMOTHERAPY Proceedings of the 9th International Congress of Chemotherapy held in London, July, 1975 A. M. Geddes (Antimiaobial) East Birmingham Hospital W. Brumfitt K. Hellmann K.D. Bagshawe H. Smith EJ. Stokes F. Wrigley J.D. Williams Editorial Committee K. Hellmann, Chairman (Anticancer) Imperial Cancer Research Fund, London. J. D. Williams (Antimiaobial) The London Hospital Medical CoUege. Congress Organising Committee I. Phillips M.R.W. Brown D.G.James C. Stuart-Harris R.G.Jacomb D.T.D. Hughes T.Connors H.P. Lambert P. Turner A.M. Geddes D.Armitage D.Crowther D.8. Reeves R.E.O. Williams International Society of Chemotherapy Executive - to July 1975 P.Malek C. Grassi G.H. Werner H.P. Kuemmerle Z.Modr K.H. Spitzy P. Rentchnick H. Ericsson G.M. Savage H. Umezawa

Preface The International Society of Chemotherapy meets every two years to review progress in chemotherapy of infections and of malignant disease. Each meeting gets larger to encompass the extension of chemotherapy into new areas. In some instances, expansion has been rapid, for example in cephalosporins, penicillins and combination chemotherapy of cancer - in others slow, as in the field of parasitology. New problems of resistance and untoward effects arise; reduction of host toxicity without loss of antitumour activity by new substances occupies wide attention. The improved results with cancer chemotherapy, especially in leukaemias, are leading to a greater prevalence of severe infection in patients so treated, pharmacokinetics of drugs in normal and diseased subjects is receiving increasing attention along with related problems of bioavailability and interactions between drugs. Meanwhile the attack on some of the major bacterial infections, such as gonorrhoea and tuberculosis, which were among the first infections to feel the impact of chemotherapy, still continue to be major world problems and are now under attack with new agents and new methods. From this wide field and the 1,000 papers read at the Congress we have produced Proceedings which reflect the variety and vigour of research in this important field of medicine. It was not possible to include all of the papers presented at the Congress but we have attempted to include most aspects of current progress in chemotherapy. We thank the authors of these communications for their cooperation in enabling the Proceedings to be available at the earliest possible date. The method of preparation does not allow for uniformity of typefaces and presentation of the material and we hope that the blemishes of language and typographical errors do not detract from the understanding of the reader and the importance of the Proc~edings. K. HELLMANN, Imperial Cancer Research Fund A. M. GEDDES, East Birmingham Hospital J. D. WILLIAMS, The London Hospital Medical College vii

Contents Tissue Binding of Antibiotics 1 C. M. Kunin The In Vivo Significance of Antibiotics in the Tissues 7 H. Mattie Antibiotic Concentrations in Human Interstitial Fluid 13 J. S. Tan Antibiotic Activities Inside Leucocytes J. A. Raeburn, E. Watson, E. J. Hanson, and T. Johnston 17 Antibiotic Concentrations in Sinus Secretions. 25 A.-S. Malmborg Antibiotics in Respiration Secretions in the Experimental Animal J. E. Pennington Antibiotic Concentrations in the Human Bone Marrow and Bone Marrow Hematoma S. Kondo Passage of Doxycycline into the Thoracic Duct urmph after Oral and Intravenous Administration in Man P.-A. ~dh, K.-E. Andersson, H. Dencker, and M. herlund Concentration of Antibacterials in Human Seminal Plasma A.-S. Malmborg, K. Dornbusch, R. Eliasson, and C. Lindholmer 35 43 47 53 Antibiotic Concentrations in Intracranial Pus: from a Collaborative Project J. de Louvois and R. Hurley A Study 61 ix

x Concentrations o~ Antibiotics in Bronchiolar Secretions o~ the Patients with Chronic Respiratory In~ections K. Matsumoto and Y. Uzuka Further Studies on the Protein Binding Inhibitor o~ Antimicrobials in Uremic Sera W. A. Craig Antimicrobial Therapy in Patients on Haemodialysis J. Verhoe~ and P. L. Oe Ageing and Antimicrobial Therapy P. L. Oe and J. Verhoe~ Pharmacokinetics o~ Carbenicillin Through Di~~erent Dialysis Membranes G. Naumann, M. Holtz, W. MUntner, W. Nimmrich, E. Budde, and H. Klinkmann The E~~ect o~ ph on the Transport o~ Oligosaccharidic Antibiotics Across a Membrane Model System L. Favalli, M. C. Chiari, A. Rozza, and F. Piccinini Prolonged Excretion o~ Gentamicin in Patients with Normal Renal Function G. Kahlmeter, T. Hallberg, S. Jonsson, C. Kamme, and B. Ursing The Use o~ Gentamicin in Patients with Impaired Renal Function J. L. Anderton, E. Hanson, and J. A. Raeburn Comparative Biliary Excretion o~ Ampicillin, Metampicillin, and Carbenicillin M. Pinget, J. M. Brogard, and J. Lavillaureix CONTENTS 73 79 85 93 101 107 115 121 127 Sisamicin: Serum Hal~-Li~e and Distribution Space in Patients with Normal and Impaired Renal Function 141 S. Roth, K. G. Naber, M. Scheer, and H. Lange Serum Levels o~ Nalidixic Acid in Patients with Impaired Renal Function 151 G. Gundlach, G. Linzenmeier, and P. Bruehl Biotrans~ormation o~ the Antibiotics in the Patients and Animals with Liver Impairment O. Kunii, K. Fukaya, and K. Mashimo 159

CONTENTS xi Comparative Pharmacokinetics of Cephalosporins 165 V. P. Jakovlev, V. S. Klimova, and E. A. Rudzit Ten Years' Experience with the Blood Level Duration Test 171 J. Bang Statistical Aspects of the Blood-Level Duration Test M. W. Bentzon 177 Effect of Recumbency on Erythromycin Absorption 183 R. L. Parsons and G. M. Paddock Cholestyramine Induced Antibiotic Malabsorption R. L. Parsons, G. M. Paddock, and G. M. Hossack Investigation of the Gastrointestinal Absorption of Ampicillin, Cephalexin, and Pivampicillin H. Lode 191 199 Comparative Bioavailability of Oral Ampicillin Suspension, Pivampicillin Hydrochloride Salt (Capsule), Pivampicillin Pamoate Salt (Suspension) and Pivampicillin Probenecid Salt (Tablet) in Man 205 G. Hitzenberger, P. E. Wittreich, I. Jaschek, A. Korn, J. Bonelli, and D. Magometschnigg Biotransformation of Ampicillin, Amoxicillin and Oxacillin in Healthy Subjects and in Patients with Bacteriuria H. Graberm, T. Perenyi, M. Arr, and E. Ludwig Antibiotic Absorption in Crohn's Disease R. L. Parsons, G. M. Paddock, G. M. Hossack, and D. M. Hailey A Pharmacokinetic Study of the Combination Rifampicin Plus Trimethoprim in Man W. Brumfitt, V. M. Moss, E. Brooker, and J. M. T. Hamilton-Miller The Excretion and Metabolism of Talampicillin in Rat, Dog, and Man D. J. Jeffery, K. H. Jones, and P. F. Langley The Excretion of Hetacillin Methoxymethyl Ester (BL-P176l) into the Prostatic Fluid of the Dog T. B. Kjaer and P. O. Madsen 213 219 231 237 243

xii Kidney Distribution of Carbenicillin, Indanyl Carbenicillin, Tobramycin, Fosfomycin, and Cefazolin R. di Carlo, D. Savoia, G. Fontana, and G. Ceccarelli Studies on Tissue Distribution of Antibiotics - An Attempt to Estimate Tissue Levels from Macro-Autoradiograms J. Shimada, Y. Ueda, M. Saigusa, and R. Tsukuda Immune Responsiveness to a-lactam Antibiotics J. M. Dewdney and B. Weston Rifampicin-Induced Antibodies S. Worlledge Possible Mechanisms in Pathogenesis of NitrofUrantoin-Induced Lung Disease P. Cole Assessing Untoward Effects A. Herxheimer Antimicrobial Usage in the U. S. A. W. A. Craig and K. P. Sarver CONTENTS 249 255 261 273 279 287 293 Prospects for Control of Antibiotic Usage. 299 C. M. Kunin Antibiotic Induced Diarrhoea and Colitis in Orthopaedic In-Patients 307 R. L. Parsons, J. Salfield, and J. P. Beavis Abnormalities in the Fecal Flora of Subacute Myelo-Optic Neuropathy (SMON) Patients and Effects of Clioquinols on Human Intestinal Flora R. Nakaya, H. Inugami, T. Mitsuoka, anda. Igata Effect of Chloramphenicol on Phagocytic Activity in Human Polymorphonuclear Cells N. Ki tani and Y. Kokubun The Effect of Rifampicin on Plasma Glutamyl Transpeptidase, Salicylamide Glucuronide Formation and D-Glucaric Acid Excretion K. Malaka-Zafiriu, G. Katzos, J. Sotiriu, B. Danielides, and Chr. Cassimos 315 321 327

CONTENTS Side-Effects of High-Dose Dicloxacillin Therapy H. KOhler, T. R. Weihrauch, W. Prell wit z, and D. HOffler Neurotoxicity of Different Penicillins and the Effect of Diazepam and Phenytoin on Penicillin Induced Convulsions T. R. Weihrauch, H. KOhler, D. Hoffler, H. Rieger, and J. Krieglstein xiii 333 339 Theoretical Basis and Experimental Studies on the Prevention of Allergic Reactions to Penicillins by a Monovalent Benzylpenicilloyl Hapten A. L. de Weck, O. Toffler, M. KOleckarova, and H. Spengler Clinical Trial of a Monovalent Benzylpenicilloyl Hapten Inhibitor (RO 6-0787) in Penicillin Allergy M. C. Vonlanthen, F. Jeunet, K. H. Schulz, and J. P. Girard Neuromuscular Blocking Activity of Aminoglycoside Antibiotics A. G. Paradelis, C. Triantaphyllidis, and G. Logaras 351 359 Meningococcal Prophylaxis: Problems with Minocycline D. W. Gump and W. L. Fanning Vibramycin Curing 8,ymptoms and Enlargement of Thyroid Gland in Goiter O. M. El-Din Awad 373 Chemotherapy of the Patients with Liver Diseases 379 K. Mashimo, O. Kunii, and K. Fukaya Adverse Reactions under Intermittent Rifampicin Regimens 385 M. Zierski Pharmacokinetic and Pharmacological Interactions of Antibacterial Drugs E. R. Garrett and P. H. Hinderling Drug Interactions in Chemotherapy S. E. Smith Interactions of Nitrofurantoin with Other Drugs in the Human Organism H. Hueller, I. Amon, and K. Amon 393 407 '. 417

xiv In Vitro Studies or Chemical Interaction or Gentamicin or Tobramycin in Combination with Lincomycin or Clindamycin....... H. A. Holt and D. S. Reeves Potentiation or Hepatic Damage by the Interaction or Tetracycline and Phenothiazine Derivatives: Therapy and Occurrence or New Psychiatric Symptomatology...... A. M. Singh and J. S. Falletta Contributors CONTENTS 423 429 435